logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Review

Embedding treatment in stronger care systems

Rojek A, Fieggen J, Paterson A, Byakika-Kibwika P, Camara M,  et al.
2024-12-12 • Lancet Infectious Diseases
2024-12-12 • Lancet Infectious Diseases
Journal Article
|
Review

Ebola disease: Bridging scientific discoveries and clinical application

Rojek A, Fieggen J, Apiyo P, Caluwaerts S, Fowler RA,  et al.
2024-12-01 • Lancet Infectious Diseases
2024-12-01 • Lancet Infectious Diseases

The west Africa Ebola disease epidemic (2014-16) marked a historic change of course for patient care during emerging infectious disease outbreaks. The epidemic response was a failure ...

Journal Article
|
Research

A standardised phase III clinical trial framework to assess therapeutic interventions for Lassa fever

Olayinka A, Bourner J, Akpede GO, Okoeguale J, Abejegah C,  et al.
2022-01-06 • PLOS Neglected Tropical Diseases
2022-01-06 • PLOS Neglected Tropical Diseases
BACKGROUND
Only one recommendation currently exists for the treatment of Lassa fever (LF), which is ribavirin administered in conjunction with supportive care. This recommendation is...
Journal Article
|
Research

Experimental Treatment of Ebola Virus Disease with Brincidofovir

Dunning J, Kennedy SB, Antierens A, Whitehead J, Ciqlenecki I,  et al.
2016-09-09 • PLOS One
2016-09-09 • PLOS One
The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against E...